Lubrizol's Acquisition of Vesta Broadens Offering for Global Medical Device Industry
(Thomson Reuters ONE) -
CLEVELAND, September 26, 2014 - The Lubrizol Corporation's recent acquisition
of Vesta, a leading contract manufacturer for the global medical device
industry, broadens Lubrizol's life science manufacturing capabilities,
applications and material portfolio with access to silicone and a variety of
other thermoplastics utilized in medical devices. Both Lubrizol LifeSciences and
Vesta showcased their expanded capabilities at the MEDTEC China 2014 exhibition
Sept. 25-26 at the Shanghai World Expo Exhibition and Convention Center.
Headquartered in Franklin, WI, Vesta has three manufacturing locations in the
U.S. The company offers disposable silicone medical components and provides
silicone molding, extrusion, sheeting, dip-casting and assembly services. As a
full service provider to medical device original equipment manufacturers, Vesta
also supplies precision thermoplastic extruded tubing, assemblies and secondary
operations to its medical device customers. The medical device manufacturer has
a long history of medical design engineering experience with clinical device
applications in cardiology, urology, wound care and bariatrics.
"The addition of Vesta significantly enhances our life science offerings through
the combination of strong polymer technology, applications know-how, and world-
class component manufacturing," says Deb Langer, vice president and general
manager, Lubrizol LifeSciences. "As medical device companies look for total
solution providers, the expertise and capabilities of Vesta give us the ability
to provide a more valuable offering to these customers on a global basis."
Vesta is part of Lubrizol Advanced Materials Inc.
About The Lubrizol Corporation
The Lubrizol Corporation, a Berkshire Hathaway company, is a technology-driven
global company that combines complex, specialty chemicals to optimize the
quality, performance and value of customers' products while reducing their
environmental impact. It produces and supplies technologies to customers in the
global transportation, industrial and consumer markets. These technologies
include lubricant additives for engine oils, driveline and other transportation-
related fluids, industrial lubricants, as well as additives for gasoline and
diesel fuel. In addition, Lubrizol makes ingredients and additives for home
care and personal care products and pharmaceuticals, and specialty materials,
including plastics technology and performance coatings in the form of specialty
resins and additives.
With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing
facilities in 17 countries, as well as sales and technical offices around the
world. Founded in 1928, Lubrizol has approximately 7,500 employees worldwide.
Revenues for 2013 were $6.4 billion. For more information, visit Lubrizol.com.
Media Contact
Ben Patti
(216) 447-5827
benjamin.patti(at)lubrizol.com
www.lubrizol.com
###
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Lubrizol via GlobeNewswire
[HUG#1858687]
Unternehmensinformation / Kurzprofil:
Datum: 26.09.2014 - 15:54 Uhr
Sprache: Deutsch
News-ID 341879
Anzahl Zeichen: 3831
contact information:
Town:
Wickliffe, Ohio
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 121 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Lubrizol's Acquisition of Vesta Broadens Offering for Global Medical Device Industry"
steht unter der journalistisch-redaktionellen Verantwortung von
Lubrizol (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
